Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC.Financial_Report.xls
EX-31.1 - EXHIBIT 31.1 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex311.htm
EX-31.2 - EXHIBIT 31.2 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex312.htm
EX-10.31 - EXHIBIT 10.31 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex1031.htm
EX-10.32 - EXHIBIT 10.32 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex1032.htm
EX-10.30 - EXHIBIT 10.30 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex1030.htm
EX-10.33 - EXHIBIT 10.33 - CHINA PEDIATRIC PHARMACEUTICALS, INC.ex1033.htm
10-K - CHINA PEDIATRIC PHARMACEUTICALS FORM 10-K - CHINA PEDIATRIC PHARMACEUTICALS, INC.form10k.htm
Exhibit 32.1
 
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Jun Xia, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of China Pediatric Pharmaceuticals, Inc. on Form 10-K for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of China Pediatric Pharmaceuticals, Inc..
 
         
   
By:
 
/s/    JUN XIA
Date: April 16, 2012
 
Name:
 
Jun Xia
   
Title:
 
Chief Executive Officer


I, Minggang Xiao, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of China Pediatric Pharmaceuticals, Inc. on Form 10-K for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of China Pediatric Pharmaceuticals, Inc..
 
         
   
By:
 
/s/    MINGGANG XIAO
Date: April 16, 2012
 
Name:
 
Minggang Xiao
   
Title:
 
Chief Financial Officer